⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2821825 | 1.00 | — | — | |
| SCHEMBL1035557 | 1.00 | — | — | |
| SCHEMBL244944 | 0.79 | — | — | |
| SCHEMBL244945 | 0.79 | — | — | |
| SCHEMBL258961 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL10538997 | 0.75 | — | — | |
| SCHEMBL23749582 | 0.72 | TSHR (0.31) | — | |
| SCHEMBL28432560 | 0.72 | — | — | |
| SCHEMBL2566215 | 0.72 | — | — | |
| SCHEMBL2566216 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346600-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. | 2025-11-13 | — | — | US | disclosed |
| WO-2025054488-A1 | TRICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2024259171-A9 | KEAP1 INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. (US) | 2025-01-23 | — | — | WO | disclosed |
| US-20250011291-A1 | KEAP1 INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. | 2025-01-09 | — | — | US | disclosed |
| WO-2024259171-A2 | KEAP1 INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20230027026-A1 | FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF | BLUEPRINT MEDICINES CORPORATION | 2023-01-26 | — | — | US | disclosed |
| WO-2021062327-A1 | FUSED PYRIMIDINE COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF | JUBILANT BIOSYS LIMITED (IN) | 2021-04-01 | — | — | WO | disclosed |
| EP-2167492-B1 | NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS | HANMI SCIENCE CO LTD (KR) | 2015-10-14 | — | — | EP | disclosed |
| US-8188102-B2 | Amide derivative for inhibiting the growth of cancer cells | HANMI HOLDINGS CO., LTD. (KR) | 2012-05-29 | — | — | US | disclosed |
| US-20100179120-A1 | NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS | HANMI PHARM. CO., LTD. (KR) | 2010-07-15 | — | — | US | disclosed |
| CN-1061651-C | herbicidal 1-alkenyl tetrazolinones | BAYER AGROCHEM KK (JP) | 2001-02-07 | — | — | CN | disclosed |
| US-5668087-A | Herbicidal 1-alkenyltetrazolinones | NIHON BAYER AGROCHEM K.K. (JP) | 1997-09-16 | — | — | US | disclosed |
| CN-1134934-A | Herbicidal 1-alkenyl tetrazolinones | BAYER AGROCHEM KK (JP) | 1996-11-06 | — | — | CN | disclosed |
| EP-0733624-A1 | Herbicidal 1-alkenyltetrazolinones | NIHON BAYER AGROCHEM K.K. (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-4205171-A | ANALGESICS | STERLING DRUG INC. (US) | 1980-05-27 | — | — | US | disclosed |
| US-RE29943-E | ANALGESICS | STERLING DRUG INC. (US) | 1979-03-20 | — | — | US | disclosed |
| US-4127577-A | Aminomethanobenzazocine process | STERLING DRUG INC. (US) | 1978-11-28 | — | — | US | disclosed |
| US-4032529-A | ANALGESICS | STERLING DRUG INC. (US) | 1977-06-28 | — | — | US | disclosed |
| US-3968114-A | ANALGESIC | STERLING DRUG INC. (US) | 1976-07-06 | — | — | US | disclosed |
| US-3957793-A | ANALGESICS | STERLING DRUG INC. (US) | 1976-05-18 | — | — | US | disclosed |